Amplification of 19q13.1-q13.2 sequences in ovarian cancer: G-band, FISH, and molecular studies

Cancer Genetics and Cytogenetics

Volumn 87, Issue 1, 1996, Pages 55-62

  Thompson, Floyd H ^a   Nelson, Mark A ^a   Trent, Jeffrey M ^b   Guan, Xin Yuan ^b   Liu, Yun ^a   Yang, Jin Ming ^a   Emerson, Julia ^a   Adair, Laurence ^a   Wymer, Julie ^a   Balfour, Celia ^a   Massey, Kathy ^a   Weinstein, Ronald ^a   Alberts, David S ^a   Taetle, Raymond ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 19Q; CHROMOSOME ABERRATION; CYTOGENETICS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

EID: 17444437679     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00248-0     Document Type: Article

References (32)

1. Thompson FH, Emerson J, Alberts D, Liu Y, Guan X-Y, Burgess A, Fox S, Taetle R, Weinstein R, Makar R, Powell D, Trent J (1994): Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73:33-45.
2. Thompson FH, Liu Y, Emerson J, Weinstein R, Makar R, Trent J, Taetle R, Alberts D (1994): Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chrom Cancer 10:262-266.
3. Trent JM, Thompson FH, Buick RN (1985): Generation of clonal variants in a human ovarian carcinoma studied by chromosome banding analysis. Cancer Genet Cytogenet 14:153-161.
4. Thompson FH (1991): Cytogenetic methodological approaches and findings in human solid tumors. In: The A.C.T. Cytogenetics Laboratory Manual, 2nd Ed. Barch M, ed. Raven Press Limited, New York, pp. 451-488.
5. Trent JM, Thompson FH (1987): Methods for chromosome banding of human and experimental tumors in vitro. In: Methods in Enzymology (Molecular Genetics of Mammalian Cells) Vol. 151, Gottesman M, ed. Academic Press, San Diego, pp. 267-279.
6. ISCN (1991): Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. S. Karger, Basel.
7. ISCN (1985): An International System for Human Cytogenetic Nomenclature, published in collaboration with Cytogenet Cell Genet, Karger, Basel,
8. Taetle R, Thompson F, Trent J, Emerson J, Weinstein R, Leong S, Dalton W, Salmon SE, Roe DJ, Alberts D (1995): Clinical correlations of chromosome abnormalities in human breast, melanoma and ovarian cancer: preliminary analyses of 580 patients (abstract). 6th International Workshop on Chromosomes in Solid Tumors.
9. Zhang J, Trent JM, Meltzer PS (1993): Rapid isolation and characterization of amplified DNA by chromosome microdissection: identification of IGF1R amplification in malignant melanoma. Oncogene 8:2827-2831.
10. Guan X-Y, Trent JM, Meltzer PS (1993): Generation of band-specific painting probes from a single microdissected chromosome. Hum Molec Genet 2:1117-1121.
11. Guan X-Y, Meltzer PS, Cao J, Trent JM (1992): Rapid generation of region-specific genomic clones by chromosome microdissection: isolation of DNA from a region frequently deleted in malignant melanoma. Genomics 14:680-684.
12. Boring CC, Squires TS, Tong T (1991): Cancer Statistics. American Cancer Society.
13. Cheng JQ, Godwin AK, Bellacosa A, Tagucchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR (1992): AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 89:9267-9271.
14. Nelson M, Futscher BW, Kinsella T, Wymer J, Bowden T (1992): Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc Natl Acad Sci USA 89:6398-6402.
15. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 162:156-159.
16. Aman P, Pejovic T, Wennborg A, Heim S, Mitelman F (1993): Mapping of the 19p13 breakpoint in an ovarian carcinoma between the INSR and TCF3 loci. Genes Chrom Cancer 8: 134-136.
17. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Floderus U-M, Furgyik S, Helm G, Himmelmann A, Willen H, Mitelman F (1992): Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chrom Cancer 4:58-68.
18. Trent JM (1985): Prevalence and clinical significance of cytogenetic abnormalities in human ovarian cancer. In: Ovarian Cancer, Alberts DS, Surwit EA, eds. Martinus, Nijhoff, New York, pp. 1-21.
19. Tanaka K, Boice CR, Testa JR (1989): Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 43:1-14.
20. van den Berg-Bakker CAM, Hagemeijer A, Franken-Postma EM, Smit VTHBM, Kuppen PJK, van Ravenswaay Claasen HH, Cornelisse CJ, Schrier PI (1993): Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics. Int J Cancer 53:613-620.
21. Thompson F, Emerson J, Dalton WS, Yang J-M, McGee D, Villar H, Knox S, Massey K, Weinstein R, Bhattacharya A, Trent J (1993): Clonal chromosome abnormalities in human breast carcinomas I: 28 cases with primary disease. Genes Chrom Cancer 7:185-193.
22. Trent J, Yang J-M, Emerson J, Dalton WS, McGee D, Massey K, Thompson F, Villar H (1993): Clonal chromosome abnormalities in human breast carcinomas II: 34 cases with metastatic disease. Genes Chrom Cancer 7:194-203.
23. Thompson FH, Trent JM (1987): Chromosomal segment representation profiles in human malignant melanoma, ovarian, breast, and colon carcinomas (abstract). Am J Hum Genet 41:38.
24. Trent JM, Yang J-M, Thompson FH, Leibovitz A, Villar H, Dalton WS (1987): Chromosome alterations in human breast cancer. In: Oncogenes and Hormones in Breast Cancer, Sluyser M, ed. Ellis Horwood Ltd., pp. 142-151.
25. Trent JM, Thompson FH, Alberts DS (1987): Recurring sites of chromosome change in human ovarian carcinoma (abstract). Cancer Genet Cytogenet 28:36.
26. Schneider SS, Hiemstra JL, Zehnbauer BA, Taillon-Miller P, Le Paslier DL, Vogelstein B, Brodeur GM (1992): Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma. Molec Cell Biol 12:5563-5570.
27. Amler LC, Schwab M (1992): Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA. Oncogene 7:807-809.
28. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins PV (1994): Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54:4299-4303.
29. Guan X-Y, Meltzer PS, Dalton WS, Trent JM (1994): Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nature Genet 8:155-161.
30. Guan X-Y, Cargile CB, Anzick SL, Thompson FH, Meltzer PS, Bittner ML, Taetle R, McGill JR, Trent JM (1995): Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. Cancer Res (in press).
31. Su YA, Trent JM, Guan X-Y, Meltzer PS (1994): Direct isolation of genes encoded within a homogeneously staining region by chromosome microdissection. Proc Natl Acad Sci USA 91:9121-9125.
32. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, III, Johnson BE, Skolnick MH (1994): A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.